MedPath

Comparing conventional Pap Smear with Liquid-Based Cytology for screening Cervical Cancer.

Phase 2
Conditions
Health Condition 1: C539- Malignant neoplasm of cervix uteri, unspecified
Registration Number
CTRI/2024/07/070659
Lead Sponsor
BPS GMCWomen Khanpur Kalan Sonipat
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

All female above 21 years of age

Exclusion Criteria

1.Patients with diagnosis of CIN or cervical cancer and under treatment,

2.Pregnant and postpartum female,

3.Women in their menstrual period,

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
the superior test will be known after the studyTimepoint: one year
Secondary Outcome Measures
NameTimeMethod
The superior test among the Conventional Pap Smear & Liquid Based Cytology in Screening of Cervical Cancer will be known.Timepoint: one year
© Copyright 2025. All Rights Reserved by MedPath